{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-005246","form_type":"8-K/A","ticker":"LAB","cik":"0001162194","company_name":"STANDARD BIOTOOLS INC.","filed_at":"2024-01-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.531515+00:00","generated_at":"2026-06-06T21:05:20.130428+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Standard BioTools completes SomaLogic acquisition; provides audited FY2022 and unaudited 9M2023 financials","bullets":["Acquisition closed Jan. 5, 2024; SomaLogic becomes wholly owned subsidiary of Standard BioTools.","SomaLogic FY2022 revenue $97.7M, net loss $109.2M; FY2021 revenue $81.6M, net loss $87.5M.","Pro forma unaudited combined financials filed for FY2022 and 9M2023 reflecting the acquisition.","SomaLogic had $421.8M cash and equivalents and $647.4M total assets at Dec. 31, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-005246","json":"https://secwatch.observer/filing/0001104659-24-005246.json","markdown":"https://secwatch.observer/filing/0001104659-24-005246.md","text":"https://secwatch.observer/filing/0001104659-24-005246.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1162194/000110465924005246/0001104659-24-005246-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1162194/000110465924005246/tm243472d1_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T21:05:20.130428+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}